Podcast: How Merck is looking at past epidemics and science to respond to the coronavirus outbreak
February 1, 2020
Listen as Merck’s Dr. Julie L. Gerberding, chief patient officer, and BIO’s Phyllis Arthur, VP, infectious diseases and diagnostics policy, discuss the outbreak and its public health impact
Patrick Ryan, Merck director of communications, recently discussed the coronavirus outbreak with our own Dr. Julie L. Gerberding, executive vice president and chief patient officer, and Phyllis Arthur, VP, infectious diseases and diagnostics policy at BIO, the world’s largest trade association for biotech companies.
Together, they provide an overview and insight into responding to an outbreak, lessons learned from past epidemics and the importance of communication to the global community. Additionally, they explored what role public and private organizations take when it comes to preparedness and what it takes from a scientific perspective to tackle the virus head on.